BHU Digital Repository

SUCCESSFUL VIROLOGICAL SUPPRESSION IN THE FACE OF IMMUNOLOGICAL FAILURE AMONGST HIV SEROPOSITIVE PERSONS ON ANTIRETROVIRAL TREATMENT

Show simple item record

dc.contributor.author Chima, G,A.A
dc.date.accessioned 2024-06-26T03:54:13Z
dc.date.available 2024-06-26T03:54:13Z
dc.date.issued 2021
dc.identifier.uri http://localhost:8080/xmlui/handle/123456789/2344
dc.description.abstract Background: In the absence of viral load tests as monitoring tool for people living with HIV/AIDS on antiretroviral therapy, CD4 cell count and clinical assessment were depended upon as a monitoring tool. Our clinically healthy clients with immune failure repeatedly for two to three times were switched to second line drugs. Those clinically ill with immune failure with no other known comorbidity were also switched to second line drugs. Studies have shown that some persons living with human immunodeficiency virus (HIV) who did normalise their immune status while on HAART, had viral suppression while others showed blunted immune response despite virologic suppression evidenced by low plasma HIV-1 RNA.1-5 Quality improvement programme later on set up and funded by the PEPFAR US based programme in which 1,520 clients on antiretroviral therapy were randomly selected and subjected to viral load assay. We reviewed the CD4 response of our patients on HAART at baseline and at time of viral load assay, in order to identify discordant patients and thus formulate strategies for more efficient and effective antiretroviral client treatment monitoring. Materials and Methods: Of the 1,520 clients who had their viral load assayed, we reviewed their CD4 count at baseline and at time of viral load assay. We also reviewed the age, gender distribution and the discordancy rate. Results: We found a discordant immune response to antiretroviral therapy in 165 (10.9% of 1520) clients whose viral load were assayed. Univariate analysis showed that low CD4 counts less than 100cells/ml at baseline, less than 50% gain in CD4 count more than one year after commencement of antiretroviral therapy and time on antiretroviral therapy more than three years, with P-value of 0.035 were associated with immunological failure. Conclusion: We therefore concluded that approximately 11 per cent of our clients with immune response failure had successful viral suppression. en_US
dc.language.iso en_US en_US
dc.publisher Nigerian Journal of Family Practice en_US
dc.relation.ispartofseries 10;1
dc.subject Immunological failure, Virologic failure, viral suppression en_US
dc.title SUCCESSFUL VIROLOGICAL SUPPRESSION IN THE FACE OF IMMUNOLOGICAL FAILURE AMONGST HIV SEROPOSITIVE PERSONS ON ANTIRETROVIRAL TREATMENT en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search BHUDR


Advanced Search

Browse

My Account